Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO6807952 in type 2 diabetes mellitus inadequately controlled with metformin
NCT01516476Phase 2Terminated
- Sponsor
- Roche
- Start
- Nov 2011
- Primary completion
- Jan 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RO-6807952 in type 2 diabetes mellitus (T2DM), sponsored by Roche. Started Nov 2011; status: terminated.
02
Drugs
RO-6807952
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01516476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01516476.